TYK2 inhibitor (Atomwise)

N/A

Report date: 2025/06/11 11:17:45
NME

Base Information

Drug NameTYK2 inhibitor (Atomwise)
Drug Alias NameATMW-DC
ClassificationSmall molecules
Mechanisms of ActionImmunomodulatorsTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsInflammationAutoimmune DiseasesPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtomwise Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtomwise Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A